China Cell Culture Market Size & Outlook, 2026-2033
- Biotechnology
- Cell Culture & Stem Cell
- Cell Culture Market Outlook
- Cell Culture & Stem Cell
Global Market
Related Markets
Ask a question about the cell culture market
China cell culture market highlights
- The China cell culture market generated a revenue of USD 1,242.6 million in 2025 and is expected to reach USD 4,028.2 million by 2033.
- The China market is expected to grow at a CAGR of 16.7% from 2026 to 2033.
- In terms of segment, consumables was the largest revenue generating product in 2025.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cell culture market data book summary
| Market revenue in 2025 | USD 1,242.6 million |
| Market revenue in 2033 | USD 4,028.2 million |
| Growth rate | 16.7% (CAGR from 2026 to 2033) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments |
| Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, Corning Inc, Avantor Inc, BD, Eppendorf, Bio-Techne Corp, PromoCell GmbH |
Other key industry trends
- In terms of revenue, China accounted for 6.5% of the global cell culture market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China cell culture market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,028.2 million by 2033.
The cell culture market in China is highly saturated with local players, although the low cost of production drives global investments in the country for manufacturing. For instance, in December 2021, Fujifilm announced building a new center for bioprocessing media in China. The plant is aimed at providing media for biotherapeutics development, advanced therapies, & vaccines.
Moreover, China is a pioneer in stem cell research, which is projected to drive the demand for cell culture products. The presence of global players, such as Thermo Fisher Scientific, Inc. & Merck KGaA, and local suppliers, such as Global Kang Qinhuangdao Biotechnology Co., Ltd. & Guangzhou Ikeme Technology Co., Ltd., aids in meeting the diverse needs of R&D in the biopharmaceutical industry in the country.
Furthermore, China is intensifying research in cancer and cell therapies. In 2019, the Beijing Xisike Clinical Oncology Research Foundation granted funds to support the expansion of clinical and scientific research in China. In addition, several Chinese pharmaceutical companies have conducted extensive research activities to develop novel vaccines or therapies for COVID-19. Increased R&D initiatives are anticipated to significantly fuel the demand for cell culture products in the country, thus supporting market growth.
No credit card required*
Publish Date: Apr 29, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Culture Market Scope
Cell Culture Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Sartorius AG | View profile | 14,338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | www.sartorius.com |
| Avantor Inc | View profile | 14,500 | 100 Matsonford Road, Suite 200, Building One, Radnor Corporate Center, Radnor, PA, United States, 19087 | www.avantorsciences.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Corning Inc | View profile | 49,800 | One Riverfront Plaza, Corning, NY, United States, 14831 | www.corning.com |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | www.promocell.com/ |
| Eppendorf | View profile | 1001-5000 | Hamburg, Hamburg, Germany, Europe | dasgip.de |
China Cell Culture Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cell Culture Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.06% in 2025.
Horizon Databook has segmented the China cell culture market based on consumables, instruments covering the revenue growth of each sub-segment from 2021 to 2033.
The cell culture market in China is highly saturated with local players, although the low cost of production drives global investments in the country for manufacturing. For instance, in December 2021, Fujifilm announced building a new center for bioprocessing media in China. The plant is aimed at providing media for biotherapeutics development, advanced therapies, & vaccines.
Moreover, China is a pioneer in stem cell research, which is projected to drive the demand for cell culture products. The presence of global players, such as Thermo Fisher Scientific, Inc. & Merck KGaA, and local suppliers, such as Global Kang Qinhuangdao Biotechnology Co., Ltd. & Guangzhou Ikeme Technology Co., Ltd., aids in meeting the diverse needs of R&D in the biopharmaceutical industry in the country.
Furthermore, China is intensifying research in cancer and cell therapies. In 2019, the Beijing Xisike Clinical Oncology Research Foundation granted funds to support the expansion of clinical and scientific research in China. In addition, several Chinese pharmaceutical companies have conducted extensive research activities to develop novel vaccines or therapies for COVID-19. Increased R&D initiatives are anticipated to significantly fuel the demand for cell culture products in the country, thus supporting market growth.
- China Cell Culture Market Product Outlook (Revenue, USD Million , 2021-2033)
- Consumables
- Instruments
- China Cell Culture Market Application Outlook (Revenue, USD Million , 2021-2033)
- Biopharmaceutical Production
- Drug Development
- Diagnostics
- Tissue Culture & Engineering
- Cell and Gene Therapy
- Toxicity Testing
- Other Applications
Reasons to subscribe to Cell Culture Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Cell Culture Market Outlook databook
- Our clientele includes a mix of Cell Culture Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Cell Culture Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Cell Culture Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
China Cell Culture Market, 2021-2033 (US$M)
China cell culture market statistics, by product, 2021-2033 (US$M)
